Genzyme Oncology

Genzyme Oncology is the operator of cancer drug development companies. The company develops treatments for refractory chronic lymphocytic leukemia and other cancer therapies. Its services include drug discovery research, translational research, signal transduction, anti-angiogenesis, molecular receptor chemistry, and preclinical research in the field of medicinal phosphonate chemistry.